PEP/NEWS — Peptide intel. Daily.

GLP-1 RECEPTOR AGONIST USE TIED TO LOWER SEPSIS HEART DAMAGE RISK IN REAL-WORLD US COHORTTHYMULIN OUTPUT DROPS SHARPLY AS THYMUS ATROPHIES — MOST 50-YEAR-OLDS HAVE LARGELY FATTY THYMIC TISSUENICOTINAMIDE RIBOSIDE AND HIGH-INTENSITY EXERCISE PUSH MUSCLE EPIGENETIC CLOCKS IN OPPOSITE DIRECTIONSSTRUCTURED EXERCISE — NOT JUST GENERAL ACTIVITY — REVERSES SPECIFIC MOLECULAR AGING SIGNATURES IN MUSCLEEPIGENETIC CLOCK READINGS CAN BE DISTORTED BY SHORT-TERM BIOLOGICAL STRESS EVENTSPLASMA PROTEIN SIGNATURES DETECTED LIVER DISEASE UP TO 16 YEARS BEFORE CLINICAL ONSET IN NATURE AGING STUDYNEUTROPHIL EXTRACELLULAR TRAPS SHOWN TO AMPLIFY UV SKIN DAMAGE VIA CCDC25/MAPK PATHWAY IN MICEFTC LAWSUIT AGAINST HIMS & HERS TARGETS HEALTH DATA SHARING WITH ADVERTISERS AND DECEPTIVE BILLING GLP-1 RECEPTOR AGONIST USE TIED TO LOWER SEPSIS HEART DAMAGE RISK IN REAL-WORLD US COHORTTHYMULIN OUTPUT DROPS SHARPLY AS THYMUS ATROPHIES — MOST 50-YEAR-OLDS HAVE LARGELY FATTY THYMIC TISSUENICOTINAMIDE RIBOSIDE AND HIGH-INTENSITY EXERCISE PUSH MUSCLE EPIGENETIC CLOCKS IN OPPOSITE DIRECTIONSSTRUCTURED EXERCISE — NOT JUST GENERAL ACTIVITY — REVERSES SPECIFIC MOLECULAR AGING SIGNATURES IN MUSCLEEPIGENETIC CLOCK READINGS CAN BE DISTORTED BY SHORT-TERM BIOLOGICAL STRESS EVENTSPLASMA PROTEIN SIGNATURES DETECTED LIVER DISEASE UP TO 16 YEARS BEFORE CLINICAL ONSET IN NATURE AGING STUDYNEUTROPHIL EXTRACELLULAR TRAPS SHOWN TO AMPLIFY UV SKIN DAMAGE VIA CCDC25/MAPK PATHWAY IN MICEFTC LAWSUIT AGAINST HIMS & HERS TARGETS HEALTH DATA SHARING WITH ADVERTISERS AND DECEPTIVE BILLING

Last updated July 31, 2026 — I read this morning's peptide research and picked the items that mattered. Fresh brief tomorrow.

◤ Top story · Tim Ferriss
HUBERMAN AND FERRISS GO DEEP ON PEPTIDES, PERFORMANCE, AND PROTOCOLS...

*Stanford neuroscientist Andrew Huberman breaks down peptide use, performance optimization, and human protocols.*

Tim Ferriss

Featured Briefs

◤ Article · Peptide-anchored

NYC WOMAN DIES FOLLOWING INTRAVENOUS NAD+ INFUSION — EXPERTS WEIGH IN...

A fatal outcome following an IV NAD+ infusion is prompting serious scrutiny of unregulated longevity clinics. Experts contacted by Lifespan.io stress that catastrophic errors can happen when procedures outpace clinical oversight.

Lifespan.io
▶ Video

ALL THINGS PEPTIDES — DR. ANDREW HUBERMAN

Andrew Huberman, Ph.D., is a neuroscientist and tenured professor in the Departments of Neurobiology and Ophthalmology at Stanford University School of Medicine, where he runs the Huberman Lab. He is the author of Protocols: An Operating Ma

Tim Ferriss
▶ Video · Peptide-anchored

WHAT HAPPENS WHEN YOU STOP TAKING CJC-1295?

Thinking about stopping CJC-1295 but worried you'll lose your results? In this video, Regan Archibald explains what really happens when you stop, why cycling is essential, the risks of using CJC-1295 with DAC, and how proper medical supervi

Regan Archibald

More Headlines